ARPA-H's SURPASS Aims to Cut Clinical Trials from 10 Years to 4

ARPA-H launched the SURPASS program to tackle clinical trials that take over 10 years, cost $1-2 billion, and fail more than 90% of the time. Using AI, simulation, and phaseless adaptive trials, it aims to compress development timelines to under four years.

2026-10-01 ~ 2026-10-02 · 2 related posts

• ARPA-H's SURPASS Aims to Cut Clinical Trials From a Decade to Under 4 Years With AI — BraydonDymm · 2026-10-01
• ARPA-H plans to cut clinical trials from 10+ years to under 4 with AI — Afinetheorem · 2026-10-02